Skip to main content
. Author manuscript; available in PMC: 2009 Nov 2.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2007 Dec 31;71(2):407–413. doi: 10.1016/j.ijrobp.2007.10.011

Table 3.

Non-hematologic Toxicity

Level I: 15 mg/m2 (n=6) Grade 1 Grade 2 Grade 3 Grade 4
 pneumonitis 0 0 1 0
 esophageal 2 3 1 0
 nausea/vomiting 0 1 0 0
 weight loss 1 0 0 0
 fatigue 1 3 0 0
 tachycardia 1 0 0 0
 alopecia 0 0 0 0
 neuropathy 0 0 0 0
Level II: 20mg/m2 (n=6)
 pneumonitis 0 0 1 0
 esophageal 0 4 2 0
 nausea/vomiting 1 0 0 0
 weight loss 0 1 0 0
 fatigue 1 4 1 0
 tachycardia 0 1 0 0
 alopecia 0 0 0 0
 neuropathy 0 0 0 0
Level III: 25mg/m2 (n=6)
 pneumonitis 0 0 1 0
 esophageal 2 4 0 0
 nausea/vomiting 0 0 0 0
 weight loss 1 0 0 0
 fatigue 2 3 0 0
 tachycardia 1 0 0 0
 alopecia 0 3 0 0
 neuropathy 0 0 0 0